Digital interventions for anxiety and stress in working adults

Digital interventions for anxiety and stress in working adults: protocol for a real world, single arm trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13492232

Enrollment

192

Registered

2021-10-08

Start date

2021-10-13

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Feelings of stress and anxiety Mental and Behavioural Disorders

Interventions

Unmind is a digital platform designed to help working adults measure, manage and improve their mental health and wellbeing. This study will evaluate the use of content on the Unmind platform designed

(Beck, 1976), ACT

(Hayes et al., 1999) and mindfulness meditation (Kabat-Zinn, 2004). The content evaluated in this study will include 4 Series designed to help tackle anxiety and stress, listed below. Participants wi

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 16+ years 2. Eligible for access to the Unmind platform through their current employment with the participating organisation 3. Proficient in English 4. Internet access (desktop or mobile device) 5. A self-reported interest in using a brief digital intervention designed to help tackle symptoms of stress and anxiety

Exclusion criteria

Exclusion criteria: 1. Current or previous participation in an Unmind study 2. Unwilling or unable to commit to participation for the full study duration (6 weeks)

Design outcomes

Primary

Measure	Time frame
1. Anxiety measured using the Generalised Anxiety Disorder Scale at baseline, 3 weeks and 6 weeks 2. Stress measured using the Perceived Stress Scale at baseline, 3 weeks and 6 weeks	—

Secondary

Measure	Time frame
1. Wellbeing measured using the Unmind Index at baseline, 3 weeks and 6 weeks 2. Mood measured using the Patient Health Questionnaire (8 item version) at baseline, 3 weeks and 6 weeks 3. Self-efficacy measured using a single question adapted from the Mental Health Self Efficacy Scale at baseline, 3 weeks and 6 weeks 4. Acceptability measured as participant satisfaction, reasons for non-adherence, qualitative feedback and self-reported bad effects at 6 weeks. Reasons for non-engagement with the Unmind platform prior to the study will be collected at baseline.	—

Measure

Time frame

1. Wellbeing measured using the Unmind Index at baseline, 3 weeks and 6 weeks 2. Mood measured using the Patient Health Questionnaire (8 item version) at baseline, 3 weeks and 6 weeks 3. Self-efficacy measured using a single question adapted from the Mental Health Self Efficacy Scale at baseline, 3 weeks and 6 weeks 4. Acceptability measured as participant satisfaction, reasons for non-adherence, qualitative feedback and self-reported bad effects at 6 weeks. Reasons for non-engagement with the Unmind platform prior to the study will be collected at baseline.

—

Countries

England, Hong Kong, India, United Kingdom

Contacts

Public ContactRachael Taylor

research@unmind.com+44 (0)7814522979

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026